日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

The validated French CFAbd-Score reveals a lower burden of gastrointestinal symptoms in patients on Elexacaftor/Tezacaftor/Ivacaftor

经验证的法国CFAbd评分显示,服用Elexacaftor/Tezacaftor/Ivacaftor的患者胃肠道症状负担较轻。

Sermet-Gaudelus, Isabelle; Sadrieh, Pauline; Bonnel, Anne Sophie; Enaud, Raphael; Wizla, Nathalie; Languepin, Jeanne; Nangui, Ambre; Deelawon, Audrey; Rave, Johanna; Dabelow, Samira; Barucha, Anton; Zagoya, Carlos; Duckstein, Franziska; Mainz, Jochen Georg

Scoring Abdominal Symptoms in People with Cystic Fibrosis

对囊性纤维化患者的腹部症状进行评分

Tabori, Harold; Barucha, Anton; Zagoya, Carlos; Duckstein, Franziska; Dunay, Gabor A; Sadrieh, Pauline; Polte, Louise; Mainz, Jochen G

Corrigendum: Elexacaftor-Tezacaftor-Ivacaftor treatment reduces abdominal symptoms in cystic fibrosis-early results obtained with the CF-specific CFAbd-Score

更正:Elexacaftor-Tezacaftor-Ivacaftor 联合治疗可减轻囊性纤维化患者的腹部症状——使用囊性纤维化特异性 CFAbd-Score 评分获得的早期结果

Mainz, Jochen G; Zagoya, Carlos; Polte, Louise; Naehrlich, Lutz; Sasse, Lenny; Eickmeier, Olaf; Smaczny, Christina; Barucha, Anton; Bechinger, Lilith; Duckstein, Franziska; Kurzidim, Ludwik; Eschenhagen, Patience; Caley, Laura; Peckham, Daniel; Schwarz, Carsten

Dynamics of abdominal symptoms during the start of a new therapy with elexacaftor/tezacaftor/ivacaftor using the novel CFAbd-day2day questionnaire

使用新型 CFAbd-day2day 问卷评估 elexacaftor/tezacaftor/ivacaftor 新疗法开始时腹部症状的动态变化

Mainz, Jochen G; Barucha, Anton; Huang, Pu; Bechinger, Lilith; Duckstein, Franziska; Polte, Louise; Sadrieh, Pauline; Nährlich, Lutz; Eickmeier, Olaf; Van Dullemen, Suzanne; Eschenhagen, Patience; Schwarz, Carsten; Lüth, Stefan; Zagoya, Carlos; Graepler-Mainka, Ute

Elevated Levels of Toxic Bile Acids in Serum of Cystic Fibrosis Patients with CFTR Mutations Causing Pancreatic Insufficiency

囊性纤维化患者血清中毒性胆汁酸水平升高,这些患者存在CFTR基因突变,导致胰腺功能不全

Tabori, Harold; Schneider, Jochen; Lüth, Stefan; Zagoya, Carlos; Barucha, Anton; Lehmann, Thomas; Kauf, Eberhard; Barth, Astrid; Mainz, Jochen G

Elexacaftor-Tezacaftor-Ivacaftor Treatment Reduces Abdominal Symptoms in Cystic Fibrosis-Early results Obtained With the CF-Specific CFAbd-Score

Elexacaftor-Tezacaftor-Ivacaftor 联合治疗可减轻囊性纤维化患者的腹部症状——基于囊性纤维化特异性 CFAbd 评分的早期结果

Mainz, Jochen G; Zagoya, Carlos; Polte, Louise; Naehrlich, Lutz; Sasse, Lenny; Eickmeier, Olaf; Smaczny, Christina; Barucha, Anton; Bechinger, Lilith; Duckstein, Franziska; Kurzidim, Ludwik; Eschenhagen, Patience; Caley, Laura; Peckham, Daniel; Schwarz, Carsten

Diabetes induces remodeling of the left atrial appendage independently of atrial fibrillation in a rodent model of type-2 diabetes

在2型糖尿病啮齿动物模型中,糖尿病可独立于心房颤动诱发左心耳重塑。

Yosefy, Or; Sharon, Barucha; Yagil, Chana; Shlapoberski, Mark; Livoff, Alejandro; Novitski, Ilana; Beeri, Ronen; Yagil, Yoram; Yosefy, Chaim

Acute anterior uveitis after topical interferon for conjunctival intraepithelial neoplasia (CIN)

局部应用干扰素治疗结膜上皮内瘤变(CIN)后发生急性前葡萄膜炎

Naravane, Ameay V; Weber, Jacquelyn; Barucha, Grishma; Hou, Joshua H

Cardiac myocytes rendered ischemia resistant by expressing the human adenosine A1 or A3 receptor

表达人腺苷A1或A3受体的心肌细胞可获得缺血抵抗力。

Dougherty, C; Barucha, J; Schofield, P R; Jacobson, K A; Liang, B T